Analysis on the judgment values of three non-invasive score systems (LIF-5,APRI and FIB-4) for treatment indication in chronic HBV infected patients with ALT less than two times of upper limits of normal
-
摘要: 目的 对比分析诊断模型(LIF-5、APRI及FIB-4)对丙氨酸转移酶(ALT)<2×正常值上限(ULN)慢性乙型肝炎病毒(HBV)感染者治疗指征(≥ G2或 ≥ S2)的判断价值。 方法 收集1 135例接受肝脏穿刺活检术患者的临床资料,分为
结果 ≥ G2或 ≥ S2组患者占44.49%;该组男性和HBeAg阴性的构成、年龄、ALT、AST、APRI及FIB-4的平均值均高于 P<0.01)。诊断模型LIF-5=0.725+0.005×年龄+0.003×ALT+0.004×AST-0.201×(A/G)-0.002×PLT(109/L)。LIF-5分布的集中程度高于APRI和FIB-4,且判断价值优于APRI和FIB-4。LIF-5、APRI和FIB-4判断治疗指征的截断值分别为0.46、0.53和1.22。当LIF-5 ≤ 0.30时,敏感度96.8%、阴性预测值91.8%;当LIF-5>0.75时,特异度97.3%、阳性预测值87.1%。 结论 有较高比例的ALT<2×ULN慢性HBV感染者存在明显肝脏疾病进展,诊断模型LIF-5对治疗指征的判断有较好的价值,值得推广。 Abstract: Objective To comparatively analyze the judgment values of three non-invasive score systems (LIF-5,APRI and FIB-4),which were based on common indicators,for treatment indication (≥ G2 or ≥ S2) in chronic HBV infected patients with ALT less than two times of upper limits of normal (ULN). Methods The data of liver pathology and clinical characteristics in 1 135 chronic HBV infected patients with ALT<2×ULN were analyzed retrospectively.Patients were divided into (Results There were 505 cases (44.49%) with liver inflammation pathological grading ≥ G2 or fibrosis stage ≥ S2.The constituent ratios of male patients and HBeAg negative,the average age,the average values of ALT,AST,APRI and FIB-4 in (≥ G2 or ≥ S2) group were higher than those in ( P<0.01).The diagnostic model (LIF-5)=0.725+0.005×age (y)+0.003×ALT+0.004×AST-0.201×(A/G)-0.002×PLT (109/L).The concentration degree and the judgment value of LIF-5 were higher than APRI and FIB-4.The cutoff values for treatment indication of LIF-5,APRI and FIB-4 were 0.46,0.53 and 1.22,respectively.When the LIF-5 was ≤ 0.30 for treatment indication,the sensitivity and negative predictive value (NPV) were 96.8% and 91.8%.When the LIF-5 was >0.75 for treatment indication,the specificity and positive predictive value (PPV) were 97.3% and 87.1%. Conclusion There are still structural damage with liver inflammation ≥ G2 or fibrosis ≥ S2 in 44.49 per cent chronic HBV infected patients with ALT<2×ULN.The non-invasive score system with LIF-5 could predict treatment indication (≥ G2 or ≥ S2) with high accuracy,and is worth promoting. -
Key words:
- Hepatitis B /
- Chronic /
- LIF-5 /
- APRI /
- FIB-4 /
- Pathology /
- Diagnostic test
点击查看大图
计量
- 文章访问数: 146
- HTML全文浏览量: 22
- PDF下载量: 1
- 被引次数: 0